Bioequivalence of Levothyroxine Preparations for Treatment of Hypothyroidism-Reply

JAMA: The Journal of the American Medical Association

Volumn 277, Issue 15, 1997, Pages 1199-1200

  Dong, Betty J ^a   Gambertoglio, John G ^a   Greenspan, Francis S ^a   Hauck, Walter W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE;

BIOEQUIVALENCE; HUMAN; HYPOTHYROIDISM; LETTER; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 0030952919     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03540390029020     Document Type: Letter

References (4)

1. Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA. 1995;273:808-812.
2. The American Association of Clinical Endocrinologists and the American College of Endocrinology. AACE clinical practice guidelines for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 1995;1:56-62.
3. Mayor GH, Orlando T, Kurtz NM. Limitations of levothyroxine bioequivalence evaluation: analysis of an attempted study. Am J Ther. 1995;2:417-432.
4. Escalante DA, Arem N, Arem R. Assessment of interchangeability of two brands of levothyroxine preparations with a third-generation TSH assay. Am J Med. 1995; 98:374-78.